Presentation TCT 2014 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) ? 2 Year___ Presenter: Rafael Ruiz-Salmeron September 16, 2014
Presentation TCT 2014 Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival Presenter: Edison Peixoto September 16, 2014
Presentation TCT 2014 Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study Presenter: Armando P?rez de Prado September 16, 2014
Presentation TCT 2014 Bleeding events are reduced and survival improved by use of radial access during primary percutaneous coronary intervention for patients receiving glycoprotein inhibitors Presenter: Adam Brown September 16, 2014
Presentation TCT 2014 Drug Eluting Stents Versus Coronary Artery Bypass Graft surgery for Isolated Proximal Left Anterior Descending Artery Stenosis: A Meta-analysis Presenter: Alok Saurav September 16, 2014
Presentation TCT 2014 Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___ Presenter: Marije L?wik September 16, 2014
Presentation TCT 2014 Advanced Heart Failure Therapies in 2014: LVAD or Transplant? Presenter: Finn Gustafsson September 16, 2014
Presentation TCT 2014 Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis Presenter: Luis Nombela-Franco September 16, 2014
Presentation TCT 2014 Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR Presenter: Emmanouil Brilakis September 16, 2014
Presentation TCT 2014 Outcomes From The UK Hybrid CTO Registry Presenter: William Wilson September 16, 2014